A treatment that can stop patients from going blind is poised to be the first gene therapy for an inherited condition approved in the US, in what would be a major scientific milestone — and also open the door for record-breaking drug prices and novel ways to pay for them. Spark Therapeutics Inc’s Luxturna therapy crossed a key hurdle Thursday when it won backing from a group of advisers to the US Food and Drug Administration (FDA). After discussing the trial design, treatment procedure and safety profile, the panel of 16 experts voted unanimously that the drug’s ...
- An 8th planet is found orbiting a distant star, with AI's help
- This is how Google AI helped NASA discover two exoplanets
- Using AI, Nasa discovers another solar system like ours; has 8 planets
- India developing smaller 500 kg rocket to cash in on small-satellite boom
- Modified CRISPR technique treats diseases without cutting DNA
- Glimpse of a black hole's magnetic field could help understand how it feeds
- More than 500 students hired in first 5 days at IIT Delhi
- Scientists discover farthest black hole yet. It weighs 800 mn times the sun
- '52% Indians check e-mail everyday, 57% feel anxious over being unplugged'
- Cyient announces launch of India's first drone hackathon
First Published: Sat, October 14 2017. 23:22 IST